Brief: Diasorin Q2 Net Profit Adjusted €57 Million
31/07/2026 11:47
BRIEF-Diasorin Q2 Net Profit Adjusted €57 Million July 31 (Reuters) - DiaSorin SpA DIAS.MI:
REPORTS H1 REVENUE OF €602 MILLION
GUIDANCE 2026 CONFIRMED
Q2 ADJUSTED EBITDA €105 MILLION
Q2 NET PROFIT ADJUSTED €57 MILLION
Q2 REVENUE €315 MILLION
Further company coverage: DIAS.MI
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Diasorin
See all newsEquita upgrades Diasorin, sees 'solid' Q3
Brief: Diasorin Obtained FDA Approval For Fully Automated Laboratory Serology Tests For Human Parvovirus B19 Igm And Human Parvovirus B19 Igg On The Liaison Xl
Europe Research Roundup: Allianz, Mercedes-Benz, Tesco
European life sciences stocks rise on strong sector momentum
Italy - Factors to watch on September 21